NASDAQ: MAZE Maze Therapeutics, Inc. 8-K

Maze Therapeutics prices $144.7M equity offering to fund drug development through 2029

Filed April 22, 2026 · Period ending April 21, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade MAZE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 1:14 AM